secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solventum Corp (SOLV)
CIK:        0001964738
Form:       8-K
Filed at:   2025-08-13T23:59:59+00:00
Accession:  0001140361-25-030803
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Solventum amends purification & filtration sale to Thermo Fisher; consideration reduced to ~$4.0B
--------------------------------------------------------------------------------

- Amended agreement on June 25, 2025 excludes drinking water filtration business; cash consideration cut from $4.1B to ~$4.0B.
- Pro forma net income for H1 2025: $86M (vs historical $227M) after removal of business and transaction adjustments.
- Pro forma net income for FY2024: $1,677M (vs historical $479M) including $1.56B estimated pre-tax gain on sale.
- Net cash proceeds estimated at $3.89B after costs, working capital, and debt adjustments; proceeds to be used for debt paydown.
- Transaction expected to close with customary adjustments; ~$98M non-current assets remain due to delayed transfers in certain jurisdictions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1964738/000114036125030803/0001140361-25-030803-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1964738/000114036125030803/ef20053560_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-030803

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer